Kalbe Farma Tbk
Hub Segmentasi: Analisis Fundamental Umum (General Hub)
Tingkat pengembalian modal yang diinvestasikan. Nilai > 12% menunjukkan alokasi modal...
Mendeteksi kualitas laba bersih. Rasio di luar rentang -10% s/d 10% mengindikasikan l...
Rasio total utang terhadap modal ekuitas bersih.
Diagnosis Kesimpulan Sektor
Kualitas profitabilitas modal (ROIC) solid didukung oleh arus kas masuk operasional riil yang kuat (kualitas laba terjaga).
Emiten teratas dalam sektor Healthcare
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Beginner Insight:Understanding the "Architecture" helps you verify the company's physical scale and legitimacy. A global workforce usually indicates a mature, institutional player.